mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |